Hydrodynamic-based delivery of PTP1B shRNA reduces plasma glucose levels in diabetic mice
Hydrodynamic-based delivery of PTP1B shRNA reduces plasma glucose levels in diabetic mice
复制标题
DOI:
10.3892/mmr.2012.1172
复制
发表时间:
2013-01-01
影响因子:
3.4
通讯作者:
Meshkani, Reza
中科院分区:
文献类型:
--
作者:
Vakili, Sanaz;Ebrahimi, Shadi Sadat Seyyed;Meshkani, Reza
Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling which is overexpressed in the liver of diabetic animals. The aims of this study were to generate liver-specific PTP1B knockout mice using a PTP1B-short hairpin RNA (shRNA) plasmid and to investigate the effect of PTP1B inhibition on plasma glucose levels in streptozotocin-induced diabetic mice. We first validated the hydrodynamic tail vein injection in mice using a vector carrying the luciferase gene. Expression of the PTP1B gene was quantified by real-time PCR. The level of phosphorylated Akt was examined by western blot analysis. The injection of the plasmid containing firefly luciferase revealed that the highest transfer of the vector into the liver was obtained 24 h after the injection of 20 mu g plasmid. The injection of PTP1B-shRNA, but not the scrambled shRNA plasmid, resulted in a reduction in PTP1B expression levels by up to 84% in the liver of the diabetic mice. Plasma glucose levels following the injection of PTP1B-shRNA remained significantly lower in the diabetic mice for 5 days. In addition, mice receiving PTP1B-shRNA in the basal and insulin-stimulated states had higher levels of Akt phosphorylation in the liver cells compared with mice that were injected with the scrambled sequence (35 and 60%, respectively; p